US
Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
Newborn Screening: 7 - (TSH, 17OHP, G6PD, IRT, TGAL, Biotinidase, Phenylalanine)
| Test Code | NBS004 |
|---|---|
| Test Summary | Newborn Screening is a process where infants arescreened shortly after birth for a list of conditions thatare treatable, but are often not seen at birth.This panel screens for TSH, 17OHP, G6PD, IRT, TGAL, Biotinidase, Phenylalanine |
| Turn Around Time | 3 days |
| Acceptable Sample Types | Dried Blood Spots |
| NY Approved | No |
| Accreditations | CAP , ISO 15189 (NABL) |
*TAT starts after the sample and all required sample information is received at the processing laboratory.
**The CPT codes listed are in accordance with Current Procedural Terminology, a publication of the American Medical Association, and are provided for informational purposes only. CPT coding is the sole responsibility of the billing party.
This testing service has not been cleared or approved by the U.S. Food and Drug Administration. Testing services may not be licensed in accordance with the laws in all countries. The availability of specific test offerings is dependent upon laboratory location.
**The CPT codes listed are in accordance with Current Procedural Terminology, a publication of the American Medical Association, and are provided for informational purposes only. CPT coding is the sole responsibility of the billing party.
This testing service has not been cleared or approved by the U.S. Food and Drug Administration. Testing services may not be licensed in accordance with the laws in all countries. The availability of specific test offerings is dependent upon laboratory location.
This test is not available in your region United States, please select your nearest laboratory to request more information.
Revvity Sites Globally
Select your location.
Test Code:
NBS004
Test Description
Newborn Screening is a process where infants are screened shortly after birth for a list of conditions that are treatable, but are often not seen at birth. Newborn screening can prevent hundreds of thousands of instances of physical and mental disability and even death.Early detection of these conditions through Newborn Screening allows timely diagnosis and intervention making it possible to help give affected babies a healthy start to life.
Indications for Testing
An NBS test looks for developmental, genetic, and metabolic disorders in the newborn and allows timely management of the condition before the development or progression of the symptoms/disorder.
Screening is not a confirmatory diagnosis and requires further investigations which can be done by genetic testing.
Condition Description
When a baby is between 2 and 28 days old, a few drops of blood are collected from the baby’s heel. Blood collection on a filter paper by a heel prick is the standard procedure of screening newborns in most countries. This blood spots card is then sent to the Revvity Omics laboratory for further processing. The results of this screening test are then shared with your physician.
Test Methods and Limitations
Time Resolved Fluoroimmunoassay (TRFIA)
Detailed Sample Requirements
Dried Blood Spots
| Collection Container(s) | Dried blood spot card |
|---|---|
| Collection | Follow kit instructions. Briefly, allow blood to saturate the card until indicated areas are filled and blood has soaked through the card. Air dry the card at ambient temperature for at least 3 hours.
|
| Sample Condition | Follow the instructions provided with the collection set. Store the dried blood at ambient temperature for up to two days. If the specimen cannot be sent as soon as it is dry, the filter paper should be placed in a sealable plastic bag and stored in a refrigerator (≤ 8°C) or preferably in a freezer. |
| Shipping | Follow kit instructions. Double bag and ship overnight at ambient temperature. |